 Peter Baker
Concepts (226)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Addison Disease | 5 | 2014 | 39 | 1.770 |
Why?
| | Amino Acid Metabolism, Inborn Errors | 2 | 2020 | 19 | 1.450 |
Why?
| | Steroid 21-Hydroxylase | 4 | 2014 | 29 | 1.430 |
Why?
| | Metabolism, Inborn Errors | 2 | 2021 | 38 | 0.920 |
Why?
| | Ammonia | 1 | 2023 | 65 | 0.900 |
Why?
| | Adiposity | 2 | 2017 | 508 | 0.870 |
Why?
| | Autoantibodies | 6 | 2015 | 1334 | 0.870 |
Why?
| | Nutritional Status | 3 | 2023 | 298 | 0.840 |
Why?
| | Hernias, Diaphragmatic, Congenital | 1 | 2023 | 189 | 0.760 |
Why?
| | Leukodystrophy, Globoid Cell | 1 | 2020 | 8 | 0.750 |
Why?
| | Isoleucine | 1 | 2020 | 12 | 0.740 |
Why?
| | Obesity | 7 | 2018 | 2715 | 0.720 |
Why?
| | Carnitine O-Palmitoyltransferase | 1 | 2020 | 47 | 0.710 |
Why?
| | Valine | 1 | 2020 | 77 | 0.710 |
Why?
| | Fetal Macrosomia | 1 | 2020 | 56 | 0.710 |
Why?
| | Epilepsy | 1 | 2023 | 290 | 0.690 |
Why?
| | Amino Acids | 4 | 2020 | 462 | 0.690 |
Why?
| | Dietary Supplements | 2 | 2020 | 468 | 0.680 |
Why?
| | Dietary Proteins | 1 | 2020 | 131 | 0.670 |
Why?
| | Neonatal Screening | 1 | 2020 | 151 | 0.650 |
Why?
| | Infant, Newborn, Diseases | 1 | 2020 | 106 | 0.650 |
Why?
| | Mitochondria, Liver | 1 | 2018 | 70 | 0.650 |
Why?
| | Non-alcoholic Fatty Liver Disease | 2 | 2018 | 277 | 0.630 |
Why?
| | Neuroimaging | 1 | 2020 | 256 | 0.630 |
Why?
| | Fatty Acids | 2 | 2017 | 403 | 0.540 |
Why?
| | Poland Syndrome | 1 | 2014 | 1 | 0.520 |
Why?
| | Birth Weight | 1 | 2017 | 463 | 0.500 |
Why?
| | HLA-A2 Antigen | 1 | 2014 | 38 | 0.500 |
Why?
| | Vitamin B 12 Deficiency | 1 | 2014 | 74 | 0.490 |
Why?
| | HLA-B Antigens | 2 | 2011 | 55 | 0.490 |
Why?
| | Sequence Deletion | 1 | 2014 | 169 | 0.490 |
Why?
| | Sulfurtransferases | 1 | 2013 | 9 | 0.480 |
Why?
| | Glutaredoxins | 1 | 2013 | 12 | 0.480 |
Why?
| | Homocystinuria | 1 | 2014 | 63 | 0.480 |
Why?
| | Metabolomics | 2 | 2017 | 540 | 0.480 |
Why?
| | HLA-DR3 Antigen | 2 | 2012 | 77 | 0.480 |
Why?
| | Carnitine | 3 | 2020 | 65 | 0.460 |
Why?
| | Hyperglycinemia, Nonketotic | 1 | 2013 | 46 | 0.460 |
Why?
| | Gene Expression Regulation, Developmental | 1 | 2017 | 810 | 0.430 |
Why?
| | Gene Expression | 1 | 2017 | 1482 | 0.430 |
Why?
| | Genetic Predisposition to Disease | 7 | 2015 | 2262 | 0.420 |
Why?
| | Ring Chromosomes | 1 | 2010 | 3 | 0.380 |
Why?
| | Diabetes Mellitus, Type 1 | 5 | 2015 | 3358 | 0.380 |
Why?
| | Endocrine Cells | 1 | 2010 | 6 | 0.380 |
Why?
| | Muscle, Skeletal | 3 | 2019 | 1515 | 0.380 |
Why?
| | Chromosomes, Human, X | 1 | 2010 | 58 | 0.370 |
Why?
| | Tomography, X-Ray Computed | 1 | 2020 | 2433 | 0.370 |
Why?
| | Carrier Proteins | 1 | 2014 | 725 | 0.370 |
Why?
| | Mosaicism | 1 | 2010 | 62 | 0.370 |
Why?
| | Abnormalities, Multiple | 2 | 2018 | 182 | 0.370 |
Why?
| | Lipid Metabolism | 3 | 2018 | 473 | 0.360 |
Why?
| | Haplotypes | 4 | 2012 | 474 | 0.350 |
Why?
| | Face | 1 | 2010 | 164 | 0.330 |
Why?
| | Magnetic Resonance Imaging | 1 | 2020 | 3169 | 0.330 |
Why?
| | Autoimmunity | 2 | 2015 | 831 | 0.330 |
Why?
| | Genetic Variation | 1 | 2013 | 912 | 0.330 |
Why?
| | Infant | 8 | 2020 | 8254 | 0.320 |
Why?
| | Maternal Nutritional Physiological Phenomena | 3 | 2018 | 157 | 0.310 |
Why?
| | Biomarkers | 4 | 2018 | 3568 | 0.310 |
Why?
| | Humans | 27 | 2023 | 118268 | 0.310 |
Why?
| | Proteins | 1 | 2013 | 935 | 0.310 |
Why?
| | Pregnancy | 8 | 2020 | 5671 | 0.310 |
Why?
| | Mutation | 2 | 2018 | 3435 | 0.300 |
Why?
| | Male | 15 | 2023 | 57479 | 0.300 |
Why?
| | Fetus | 3 | 2020 | 690 | 0.290 |
Why?
| | Infant, Newborn | 4 | 2020 | 5230 | 0.290 |
Why?
| | Female | 19 | 2020 | 61268 | 0.280 |
Why?
| | Glycosylation | 2 | 2023 | 129 | 0.270 |
Why?
| | HLA-DRB1 Chains | 2 | 2015 | 97 | 0.230 |
Why?
| | Keto Acids | 1 | 2023 | 13 | 0.230 |
Why?
| | Oxidative Stress | 3 | 2018 | 1167 | 0.230 |
Why?
| | Prenatal Exposure Delayed Effects | 2 | 2018 | 465 | 0.220 |
Why?
| | Siblings | 1 | 2023 | 235 | 0.210 |
Why?
| | Pregnancy Complications | 2 | 2018 | 447 | 0.210 |
Why?
| | HLA-B15 Antigen | 2 | 2012 | 12 | 0.210 |
Why?
| | HLA-B8 Antigen | 2 | 2012 | 13 | 0.200 |
Why?
| | Lactic Acid | 1 | 2023 | 278 | 0.200 |
Why?
| | Mutation, Missense | 1 | 2023 | 300 | 0.200 |
Why?
| | Metabolism | 1 | 2021 | 39 | 0.200 |
Why?
| | Energy Metabolism | 2 | 2017 | 762 | 0.190 |
Why?
| | Sheep | 2 | 2020 | 762 | 0.190 |
Why?
| | Genotype | 5 | 2015 | 1870 | 0.190 |
Why?
| | Propionic Acidemia | 1 | 2020 | 3 | 0.190 |
Why?
| | Leucine | 1 | 2020 | 117 | 0.180 |
Why?
| | False Positive Reactions | 1 | 2020 | 115 | 0.180 |
Why?
| | Disease Progression | 2 | 2020 | 2477 | 0.180 |
Why?
| | Adult | 9 | 2020 | 31327 | 0.170 |
Why?
| | Colorado | 2 | 2020 | 4178 | 0.170 |
Why?
| | Insulin | 3 | 2018 | 2157 | 0.170 |
Why?
| | Amino Acids, Branched-Chain | 1 | 2018 | 32 | 0.170 |
Why?
| | Glucose | 2 | 2021 | 940 | 0.160 |
Why?
| | Dystroglycans | 1 | 2018 | 7 | 0.160 |
Why?
| | Qb-SNARE Proteins | 1 | 2018 | 6 | 0.160 |
Why?
| | Leptin | 2 | 2018 | 228 | 0.160 |
Why?
| | Preconception Care | 1 | 2018 | 28 | 0.160 |
Why?
| | Enteral Nutrition | 1 | 2020 | 172 | 0.160 |
Why?
| | Placental Insufficiency | 1 | 2019 | 104 | 0.160 |
Why?
| | Muscular Dystrophies | 1 | 2018 | 36 | 0.160 |
Why?
| | Lipids | 2 | 2021 | 591 | 0.160 |
Why?
| | Micronutrients | 1 | 2018 | 78 | 0.160 |
Why?
| | Electron Transport | 1 | 2017 | 101 | 0.150 |
Why?
| | Tandem Mass Spectrometry | 1 | 2020 | 418 | 0.150 |
Why?
| | Muscle Cells | 1 | 2017 | 42 | 0.150 |
Why?
| | Vesicular Transport Proteins | 1 | 2018 | 83 | 0.150 |
Why?
| | Autoimmune Diseases | 2 | 2011 | 398 | 0.150 |
Why?
| | Maternal-Fetal Exchange | 1 | 2018 | 156 | 0.150 |
Why?
| | Mitochondrial Diseases | 1 | 2017 | 79 | 0.150 |
Why?
| | Hyperlipoproteinemia Type I | 1 | 2016 | 7 | 0.140 |
Why?
| | Exchange Transfusion, Whole Blood | 1 | 2016 | 18 | 0.140 |
Why?
| | Oxidation-Reduction | 2 | 2020 | 935 | 0.140 |
Why?
| | Disease Susceptibility | 1 | 2018 | 330 | 0.140 |
Why?
| | Lower Extremity | 1 | 2019 | 334 | 0.140 |
Why?
| | Thyroiditis, Autoimmune | 1 | 2015 | 15 | 0.140 |
Why?
| | Retinal Diseases | 1 | 2016 | 81 | 0.130 |
Why?
| | Body Mass Index | 3 | 2018 | 2074 | 0.130 |
Why?
| | Fetal Development | 1 | 2018 | 250 | 0.130 |
Why?
| | Hyperlipidemias | 1 | 2016 | 127 | 0.130 |
Why?
| | Pediatric Obesity | 2 | 2020 | 512 | 0.130 |
Why?
| | Glycogen Synthase Kinase 3 | 1 | 2015 | 82 | 0.130 |
Why?
| | Adipogenesis | 1 | 2015 | 47 | 0.130 |
Why?
| | HLA-DP beta-Chains | 1 | 2015 | 78 | 0.130 |
Why?
| | Polymorphism, Single Nucleotide | 3 | 2015 | 2057 | 0.130 |
Why?
| | Alleles | 3 | 2015 | 829 | 0.130 |
Why?
| | Milk, Human | 1 | 2016 | 134 | 0.130 |
Why?
| | Phenotype | 2 | 2014 | 2937 | 0.120 |
Why?
| | Risk Factors | 3 | 2018 | 8958 | 0.120 |
Why?
| | Postprandial Period | 1 | 2015 | 96 | 0.120 |
Why?
| | PPAR gamma | 1 | 2015 | 187 | 0.120 |
Why?
| | Epigenesis, Genetic | 1 | 2018 | 536 | 0.120 |
Why?
| | Oxidoreductases | 1 | 2014 | 98 | 0.120 |
Why?
| | South Africa | 1 | 2014 | 163 | 0.120 |
Why?
| | beta Catenin | 1 | 2015 | 219 | 0.120 |
Why?
| | Longitudinal Studies | 2 | 2017 | 2491 | 0.120 |
Why?
| | Genetic Loci | 1 | 2015 | 281 | 0.120 |
Why?
| | Diet, High-Fat | 1 | 2015 | 247 | 0.110 |
Why?
| | Atrophy | 1 | 2013 | 164 | 0.110 |
Why?
| | Child, Preschool | 2 | 2020 | 9448 | 0.110 |
Why?
| | Cell Differentiation | 2 | 2017 | 1746 | 0.110 |
Why?
| | Fatal Outcome | 1 | 2013 | 286 | 0.110 |
Why?
| | Renin | 1 | 2012 | 35 | 0.110 |
Why?
| | HLA-DR4 Antigen | 1 | 2012 | 75 | 0.110 |
Why?
| | Hypoxia | 1 | 2018 | 957 | 0.110 |
Why?
| | Mitochondria | 1 | 2017 | 785 | 0.100 |
Why?
| | Mitochondrial Proteins | 1 | 2013 | 224 | 0.100 |
Why?
| | Adrenocorticotropic Hormone | 1 | 2012 | 152 | 0.100 |
Why?
| | Brain | 2 | 2020 | 2481 | 0.100 |
Why?
| | Gene Expression Profiling | 1 | 2017 | 1590 | 0.100 |
Why?
| | Dosage Compensation, Genetic | 1 | 2010 | 9 | 0.100 |
Why?
| | Major Histocompatibility Complex | 1 | 2011 | 220 | 0.100 |
Why?
| | Child | 4 | 2021 | 19033 | 0.090 |
Why?
| | HLA-DQ Antigens | 1 | 2011 | 176 | 0.090 |
Why?
| | Microarray Analysis | 1 | 2010 | 121 | 0.090 |
Why?
| | Hydrocortisone | 1 | 2012 | 272 | 0.090 |
Why?
| | HLA-DR Antigens | 1 | 2011 | 223 | 0.090 |
Why?
| | Insulin Resistance | 1 | 2018 | 1167 | 0.090 |
Why?
| | Linkage Disequilibrium | 1 | 2010 | 273 | 0.090 |
Why?
| | In Situ Hybridization, Fluorescence | 1 | 2010 | 310 | 0.090 |
Why?
| | Gastrointestinal Microbiome | 1 | 2016 | 538 | 0.090 |
Why?
| | DNA Mutational Analysis | 1 | 2010 | 379 | 0.090 |
Why?
| | Pedigree | 1 | 2010 | 485 | 0.090 |
Why?
| | Apoptosis | 1 | 2018 | 2461 | 0.080 |
Why?
| | Gene Frequency | 1 | 2010 | 511 | 0.080 |
Why?
| | Treatment Outcome | 2 | 2020 | 9319 | 0.080 |
Why?
| | Gene Expression Regulation | 1 | 2017 | 2435 | 0.080 |
Why?
| | Polymorphism, Genetic | 1 | 2011 | 641 | 0.080 |
Why?
| | Developmental Disabilities | 1 | 2010 | 245 | 0.080 |
Why?
| | Risk | 1 | 2010 | 849 | 0.080 |
Why?
| | Predictive Value of Tests | 1 | 2012 | 1857 | 0.070 |
Why?
| | Adolescent | 3 | 2015 | 18364 | 0.070 |
Why?
| | Severity of Illness Index | 1 | 2013 | 2659 | 0.070 |
Why?
| | Time Factors | 2 | 2016 | 6368 | 0.070 |
Why?
| | Animals | 4 | 2020 | 33152 | 0.060 |
Why?
| | Young Adult | 3 | 2018 | 10731 | 0.060 |
Why?
| | Prognosis | 1 | 2012 | 3425 | 0.060 |
Why?
| | Genetic Association Studies | 2 | 2015 | 355 | 0.060 |
Why?
| | Follow-Up Studies | 1 | 2012 | 4575 | 0.060 |
Why?
| | Retrospective Studies | 1 | 2020 | 12932 | 0.060 |
Why?
| | Cross-Sectional Studies | 3 | 2018 | 4523 | 0.050 |
Why?
| | Diet, Ketogenic | 1 | 2021 | 32 | 0.050 |
Why?
| | Administration, Intravenous | 1 | 2021 | 135 | 0.050 |
Why?
| | Vitamins | 1 | 2021 | 157 | 0.050 |
Why?
| | Drug Synergism | 1 | 2020 | 338 | 0.040 |
Why?
| | Alanine | 1 | 2019 | 102 | 0.040 |
Why?
| | Hindlimb | 1 | 2019 | 137 | 0.040 |
Why?
| | Macaca | 1 | 2018 | 51 | 0.040 |
Why?
| | Citric Acid Cycle | 1 | 2018 | 45 | 0.040 |
Why?
| | Gluconeogenesis | 1 | 2018 | 65 | 0.040 |
Why?
| | Diet, Western | 1 | 2018 | 69 | 0.040 |
Why?
| | United States | 1 | 2014 | 12496 | 0.040 |
Why?
| | Diffusion Magnetic Resonance Imaging | 1 | 2018 | 90 | 0.040 |
Why?
| | Muscle Proteins | 1 | 2019 | 218 | 0.040 |
Why?
| | Middle Aged | 2 | 2015 | 27514 | 0.040 |
Why?
| | Guatemala | 1 | 2018 | 296 | 0.040 |
Why?
| | Adiponectin | 1 | 2018 | 224 | 0.040 |
Why?
| | Fundus Oculi | 1 | 2016 | 41 | 0.040 |
Why?
| | Lactobacillales | 1 | 2016 | 6 | 0.040 |
Why?
| | Gammaproteobacteria | 1 | 2016 | 14 | 0.040 |
Why?
| | Pyruvate Kinase | 1 | 2016 | 20 | 0.040 |
Why?
| | Lipoprotein Lipase | 1 | 2016 | 62 | 0.030 |
Why?
| | Triglycerides | 1 | 2018 | 515 | 0.030 |
Why?
| | Fatty Acids, Volatile | 1 | 2016 | 47 | 0.030 |
Why?
| | Plethysmography | 1 | 2016 | 124 | 0.030 |
Why?
| | Iodide Peroxidase | 1 | 2015 | 25 | 0.030 |
Why?
| | Glycogen Synthase Kinase 3 beta | 1 | 2015 | 64 | 0.030 |
Why?
| | Remission Induction | 1 | 2016 | 246 | 0.030 |
Why?
| | Down-Regulation | 1 | 2018 | 623 | 0.030 |
Why?
| | Polyendocrinopathies, Autoimmune | 1 | 2015 | 18 | 0.030 |
Why?
| | Cohort Studies | 2 | 2016 | 5078 | 0.030 |
Why?
| | Gestational Age | 1 | 2018 | 765 | 0.030 |
Why?
| | Iron-Binding Proteins | 1 | 2015 | 38 | 0.030 |
Why?
| | Protein Tyrosine Phosphatase, Non-Receptor Type 22 | 1 | 2015 | 46 | 0.030 |
Why?
| | Pancreatitis | 1 | 2016 | 105 | 0.030 |
Why?
| | Umbilical Cord | 1 | 2015 | 84 | 0.030 |
Why?
| | CTLA-4 Antigen | 1 | 2015 | 86 | 0.030 |
Why?
| | Muscle Development | 1 | 2015 | 102 | 0.030 |
Why?
| | Fetal Growth Retardation | 1 | 2019 | 468 | 0.030 |
Why?
| | Islets of Langerhans | 1 | 2020 | 739 | 0.030 |
Why?
| | Feces | 1 | 2016 | 392 | 0.030 |
Why?
| | Linear Models | 1 | 2016 | 817 | 0.030 |
Why?
| | Breast Feeding | 1 | 2016 | 381 | 0.030 |
Why?
| | Autoantigens | 1 | 2015 | 397 | 0.030 |
Why?
| | Multivariate Analysis | 1 | 2016 | 1469 | 0.030 |
Why?
| | Body Composition | 1 | 2016 | 644 | 0.030 |
Why?
| | Liver | 1 | 2018 | 1803 | 0.020 |
Why?
| | Cells, Cultured | 1 | 2015 | 4044 | 0.020 |
Why?
| | Signal Transduction | 1 | 2020 | 4688 | 0.020 |
Why?
|
|
Baker's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts  Derived automatically from this person's publications. _
Co-Authors People in Profiles who have published with this person. _
Similar People People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
Physical Neighbors People whose addresses are nearby this person. _
|